Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Malignant neoplasm of colon and/or rectum
0.080 Biomarker disease BEFREE Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. 29258530 2017
Malignant neoplasm of colon and/or rectum
0.080 Biomarker disease BEFREE Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients. 28125800 2017
Malignant neoplasm of colon and/or rectum
0.080 Biomarker disease BEFREE Silencing peroxiredoxin-2 sensitizes human colorectal cancer cells to ionizing radiation and oxaliplatin. 28003121 2017
Malignant neoplasm of colon and/or rectum
0.080 Biomarker disease BEFREE The results suggest that Prdx2 may be an effective therapeutic target for the elimination of CSCs in colorectal cancer. 27894099 2016
Malignant neoplasm of colon and/or rectum
0.080 Biomarker disease BEFREE Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer. 25471788 2015
Malignant neoplasm of colon and/or rectum
0.080 Biomarker disease BEFREE Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling. 24125860 2014
Malignant neoplasm of colon and/or rectum
0.080 AlteredExpression disease BEFREE Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress. 24234423 2014
Malignant neoplasm of colon and/or rectum
0.080 AlteredExpression disease BEFREE Overexpression of peroxiredoxin 2 inhibits TGF-β1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer. 24920174 2014